Macitentan 1 mg | ≥99% LKT Laboratories, Inc. ET-A/B antagonist. More Information Supplier Page × Macitentan
PCI-32765 25 mg | ≥99% LKT Laboratories, Inc. BTK and IL-2-inducible kinase inhibitor. More Information Supplier Page × PCI-32765
PCI-32765 5 mg | ≥99% LKT Laboratories, Inc. BTK and IL-2-inducible kinase inhibitor. More Information Supplier Page × PCI-32765
PCI-32765 1 mg | ≥99% LKT Laboratories, Inc. BTK and IL-2-inducible kinase inhibitor. More Information Supplier Page × PCI-32765
MLN-4924 25 mg | ≥99% LKT Laboratories, Inc. Nedd8-activating enzyme inhibitor. More Information Supplier Page × MLN-4924
Y27632 Dihydrochloride 25 mg | ≥99% LKT Laboratories, Inc. ROCK inhibitor. More Information Supplier Page × Y27632 Dihydrochloride
MLN-2238 1 mg | ≥99% LKT Laboratories, Inc. Proteasome inhibitor, miR33b modulator. More Information Supplier Page × MLN-2238
CPI-203 25 mg | ≥99% LKT Laboratories, Inc. Triazolothienodiazepine, JQ-1 derivative; BRD inhibitor. More Information Supplier Page × CPI-203
CPI-203 5 mg | ≥99% LKT Laboratories, Inc. Triazolothienodiazepine, JQ-1 derivative; BRD inhibitor. More Information Supplier Page × CPI-203
